What Sharklet Technologies does

Sharklet Technologies, Inc. is a privately held biotechnology company headquartered in Aurora, Colorado (12635 E Montview Blvd, #211), founded in 2007. The company develops and commercializes the Sharklet micropattern, a proprietary surface technology inspired by the dermal denticles of sharkskin. The pattern is composed of millions of microscopic features arranged in a diamond geometry that physically inhibits bacteria from attaching, colonizing, and forming biofilms without the use of chemical antimicrobial agents or toxic additives. The technology is protected by multiple patents and has been independently tested by third-party laboratories in the United States, Europe, and Asia, with reported reductions of over 90% in bacterial transfer versus smooth surfaces.

The company's commercial product portfolio falls into three categories: (1) SharkletShield Germ Barrier Film — a peel-and-stick adhesive film applied to high-touch environmental surfaces in hospitality, education, transportation, commercial real estate, and restroom settings; (2) consumer products, including a Sharklet-patterned yoga mat; and (3) medical devices, specifically a Foley Urinary Catheter and an Endotracheal Tube, both incorporating the micropattern to reduce hospital-acquired infections. Sharklet monetizes through direct e-commerce sales (shop.sharklet.com), direct enterprise sales to healthcare and institutional customers, and an OEM/integration program that licenses the micropattern into partner products across a range of materials. Pricing is quote-based and not publicly disclosed; film is recommended for replacement on a roughly 90-day cycle.

The company operates with a small team (11–50 employees) and has been featured in major outlets including the New York Times, Forbes, Wired, the Washington Post, PBS NewsHour, and the Atlantic. Cumulative disclosed funding is approximately $3.7 million, sourced primarily from small grants and one early round, with the most recent funding event recorded in 2014. No current management roster beyond the co-founder/CTO and CFO is publicly listed, and ownership, investor base, and revenue figures are not disclosed in available materials.

Name

Sharklet Technologies

Legal name

Sharklet Technologies, Inc.

Website

https://sharklet.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Sharklet Technologies is a private Aurora, Colorado-based biotech firm that commercializes a patented shark-skin-inspired micropattern inhibiting bacterial attachment on surfaces without chemicals. It sells adhesive film, consumer goods, and FDA-cleared medical devices to healthcare, hospitality, education, and transportation customers.

Ownership category

akta.pro rank

Headquarters

HQ city

Aurora

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. SharkletShield Film Sales: Sale of adhesively backed SharkletShield film products for application to high-touch surfaces in commercial and consumer settings. Films are sold directly through e-commerce and to enterprise customers.
2. Medical Device Products: Sale of medical products incorporating Sharklet technology including Foley Urinary Catheter and Endotracheal Tube for healthcare settings.
3. Consumer Products: Sale of consumer products including yoga mats with Sharklet technology through e-commerce channels.
4. Technology Licensing and Integration: Working with companies to incorporate Sharklet technology into existing products and product lines. The micropattern can be added into existing products in a wide variety of materials.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Sharklet Technologies manufactures and licenses surface technologies based on a proprietary shark skin-inspired micropattern that inhibits bacterial colonization and biofilm formation without chemical antimicrobials. Its offerings span protective films, medical devices, and consumer goods designed to reduce microbial transfer in healthcare, hospitality, education, transportation, and consumer environments. The company also licenses its micropattern platform to OEMs for integration into third-party products.

Product overview

Sharklet Technologies offers a family of products built around its patented Sharklet micropattern technology - a physical surface texture inspired by shark skin denticles that inhibits bacterial growth through pattern alone without toxic chemicals. The portfolio consists of SharkletShield Germ Barrier Film (adhesive film for high-touch surfaces), Sharklet Yoga Mat (consumer wellness product), and two FDA-cleared medical devices (Foley Urinary Catheter and Endotracheal Tube) for healthcare settings. All products share the core Sharklet micropattern technology but are tailored for different applications - film and mat for consumer/commercial surfaces, and catheters/tubes for medical device applications.

Differentiator

Problem solved

Functional benefit

Brands

• SharkletShield: Adhesive film product line featuring the Sharklet micropattern for application to high-touch surfaces to inhibit bacterial growth.

Products and services

• SharkletShield Germ Barrier Film Adhesive-backed protective film featuring the Sharklet micropattern that is applied to high-touch surfaces in commercial environments to inhibit bacterial transfer without chemical biocides or disinfectants. Designed for facility managers and procurement teams in hospitality, education, healthcare, transportation, and commercial real estate.
• Sharklet Yoga Mat A textured yoga mat produced with Sharklet's shark skin-inspired micropattern surface intended to inhibit bacterial buildup between cleanings. Sold direct-to-consumer through the Sharklet online store.
• Sharklet Foley Urinary Catheter An indwelling Foley urinary catheter whose outer surface is patterned with Sharklet's proprietary micropattern to inhibit bacterial colonization and reduce catheter-associated urinary tract infections. Targeted at hospitals, infection control teams, and medical device distributors.
• Sharklet Endotracheal Tube Endotracheal tubing whose surface features the Sharklet micropattern, intended to inhibit bacterial colonization associated with ventilator-associated pneumonia. Aimed at ICU and anesthesiology departments in hospitals and at medical device OEMs.
• Sharklet Technology Partner Integration A licensing and integration offering that enables manufacturers to apply the Sharklet micropattern to their own products (such as medical devices or consumer goods) for bacterial-inhibiting properties. Designed for OEM partners, medical device manufacturers, and product developers.

Quantifiable outcome

• Over 90% less bacterial transfer on Sharklet surfaces compared to smooth surfaces
• +1 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• University of Colorado Anschutz Medical CampusminorOthersLocated near the University of Colorado Anschutz Medical Campus, Sharklet benefits from proximity to academic medical research environment.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bio-Gate AG: German antimicrobial technology company offering surface coatings and additives (including silver-ion based) that inhibit bacterial growth on materials. Directly comparable as a competing antimicrobial surface technology provider targeting similar medical device and consumer product integrations.
• Sciessent (Agion): Provider of built-in antimicrobial technologies (silver and copper-ion based) that inhibit bacterial growth on products and surfaces. Comparable because both companies sell antimicrobial efficacy into OEM product integration and surface-protection use cases across consumer and healthcare markets.
• Cupron: Antimicrobial copper-based technology company embedding copper into surfaces, textiles, and polymers to inhibit bacteria, fungi, and viruses. Directly comparable to Sharklet as a competing non-traditional (copper-based vs. pattern-based) antimicrobial mechanism targeting similar surface-protection applications.
• Bactiguard: Swedish medtech company applying a noble metal alloy coating to medical devices (catheters, endotracheal tubes, urinary catheters) to reduce hospital-acquired infections. Highly comparable to Sharklet's medical device business line and a direct competitor in coated infection-prevention devices.
• Covalon Technologies: Canadian medical device company specializing in antimicrobial coatings and infection prevention technologies for wound care and medical devices. Comparable because it sells antimicrobial surface technologies specifically into hospital infection-prevention applications, mirroring Sharklet's clinical go-to-market.

Broad incumbents

• Microban International: Largest branded built-in antimicrobial product protection provider, offering chemistry-based antimicrobial additives integrated into consumer and industrial products. A broader incumbent in the same antimicrobial surface space, though its chemistry-based mechanism contrasts with Sharklet's physical pattern approach.
• Surmodics: Provider of surface modification coatings and drug-delivery technologies for medical devices. Comparable as a medical device surface coating specialist serving similar OEMs and catheter manufacturers, though with a broader portfolio beyond antimicrobial functionality.
• DSM Biomedical: Biomedical materials business (part of dsm-firmenich) that develops antimicrobial and biocompatible coatings for medical devices including implants and catheters. Comparable because it sells antimicrobial surface technology into the same hospital infection-prevention market.

Emerging players

• Nolla Antimicrobial: Finnish startup developing polymer-based antimicrobial technology that can be incorporated into coatings, plastics, and textiles. Comparable as an emerging antimicrobial technology player with similar OEM integration value proposition, though at an earlier commercial stage.

Others

• Specialty Coating Systems (SCS): Provider of parylene and other conformal coatings used in medical device surface modification, including antimicrobial applications. Comparable as a precision surface technology provider serving medical device OEMs with protective and functional coatings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/SharkletTechnologies
• LinkedInlinkedin.com/company/sharklet-technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sharklet Technologies